| Cash Flow | 2026-03-31 |
|---|---|
| Net income | 196,051 |
| Depreciation and amortization | 14,383 |
| Deferred income taxes | 32,138 |
| Stock-based compensation, net of amounts capitalized | 121,627 |
| Non-cash lease expense | 1,747 |
| Accretion of discount on marketable securities, net | 7,581 |
| Amortization of deferred contract costs | 13,478 |
| Impairment of long-lived assets | 0 |
| Other | -314 |
| Accounts receivable | 16,879 |
| Prepaid expenses and other assets | 8,272 |
| Deferred contract costs | 14,490 |
| Accounts payable, accrued expenses and other liabilities | 4,268 |
| Deferred revenue | -8,115 |
| Operating lease liabilities | -2,211 |
| Net cash provided by operating activities | 326,458 |
| Cash paid for acquisition, net of cash acquired | 26,528 |
| Purchases of property and equipment | 0 |
| Purchases of intangible assets | 62 |
| Internal-use software development costs | 8,901 |
| Purchases of marketable securities | 389,159 |
| Maturities of marketable securities | 561,434 |
| Sales of marketable securities | 10,386 |
| Net cash provided by (used in) investing activities | 147,170 |
| Proceeds from issuance of common stock upon exercise of stock options and common stock warrants | 9,784 |
| Proceeds from issuance of common stock in connection with the employee stock purchase plan | 3,892 |
| Taxes paid related to net share settlement of equity awards | 40,839 |
| Repurchase of common stock | 431,652 |
| Payment of contingent consideration related to a business combination | 5,249 |
| Payment of excise taxes on share repurchases | 0 |
| Net cash used in financing activities | -464,064 |
| Net increase (decrease) in cash and cash equivalents | 9,564 |
| Cash and cash equivalents, beginning of period | 209,614 |
| Cash and cash equivalents, end of period | 219,178 |
Doximity, Inc. (DOCS)
Doximity, Inc. (DOCS)